The difference of the effect of ARB on blood pressure and CARDIac functiOn in patients with essential hypertension

Trial Profile

The difference of the effect of ARB on blood pressure and CARDIac functiOn in patients with essential hypertension

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Jul 2015

At a glance

  • Drugs Azilsartan (Primary) ; Olmesartan medoxomil (Primary)
  • Indications Essential hypertension
  • Focus Pharmacodynamics
  • Acronyms CARDIO
  • Most Recent Events

    • 27 Jul 2015 Status changed from not yet recruiting to completed as per University Hospital Medical Information Network - Japan.
    • 25 Jul 2014 Planned number of patients changed from 60 to 30 as reported by University Hospital Medical Information Network - Japan.
    • 01 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top